Information for Medical Trainees

Hematology Residency Training Program

The Hematology Residency Training Program is proud to provide an extremely strong training experience. The residents who complete our program are fully prepared to excel in independent practice.

We have a world-class Bone Marrow Transplant Program as well as an internationally renowned Thrombosis Program with impressive research funding and productivity.  We provide a great degree of flexibility in the Residency Training Program in order to meet the career needs of our candidates, with significant elective time for each resident to individualize their program based on their particular interests.

The division is extremely supportive of the Hematology Training Program with a strong commitment to education and the CanMEDS philosophy.  Strengths of our educational program include a rigorous academic curriculum, a culture of ongoing formative evaluation and unique longitudinal clinics that teach residents to become independent medical experts in hematology. Our graduates have established successful careers with a wide range of interests including community hematology, basic science research, clinical research and academic practice with many becoming internationally recognized leaders in their fields.

 Thrombosis Fellowship Program

The Thrombosis Clinical Fellowship program of the Division of Hematology at the University of Ottawa is based in an active, academic, tertiary care subspecialty service. The Thrombosis Program and its members are engaged in a wide variety of innovative clinical and research activities in the areas of (1) Diagnosis and treatment of venous and arterial thromboembolic disease and (2) Management of thrombophilia. Areas of research activity include basic science, clinical health, economic and outcomes research.

The objectives of the Clinical Fellowship are to train high level specialists in thrombosis. The fellows are expected to develop an in-depth knowledge of the physiology, pathology, diagnosis and treatment of thrombotic diseases through a variety of activities, including direct inpatient and outpatient care, clinical and basic research and other academic activities.

The Thrombosis Program at the Ottawa Hospital runs daily Thrombosis Clinics (365 days/year) with referrals from Ottawa and surrounding communities. There are approximately 13,000 visits per year for investigation or treatment for venous thrombosis, thrombophilia or anticoagulation management. In addition, we provide consult service to > 1000 in-patients at 2 campuses of the Ottawa Hospital (~1000 patient beds). The expectation is that at the end of training you will be able to perform as an expert thrombosis consultant.

Educational and Training Objectives

The general objective for the fellows is to acquire clinical skills pertaining to the diagnosis and treatment of thrombotic diseases including but not limited to diagnosis (clinical, lab and imaging) of deep vein thrombosis, pulmonary embolism, other thrombotic disease, thrombophilia (acquired and genetic) and peri-operative anticoagulation.

Specific objectives are to demonstrate expertise in:

  • The use of spiral CT scan for the diagnosis of PE, VQ scan for the diagnosis of PE, ultrasound for the diagnosis of DVT, Spiral CT and venography.
  • Laboratory and clinical diagnosis and management implications of Protein C, S and AT deficiency, Factor V Leiden, Prothrombin Gene variant, Hyperhomocysteinemia and Antiphospholipid antibody syndrome.
  • Laboratory diagnosis and clinical management of HIT.
  • Known indications, complications and limitations for IVC filters ‚Äď permanent and retrievable.
  • Duration of anticoagulation for thrombotic disease including DVT and PE.
  • The diagnosis and therapeutic management of mesenteric vein thrombosis, cerebral sinus thrombosis, central retinal artery and central retinal vein occlusion.
  • The diagnosis and management of thromboembolism in pregnancy.
  • The diagnosis, risk stratification and anticoagulation for atrial fibrillation, peripheral arterial disease and stroke.
  • Order to counsel patients on birth control and thrombosis and hormone replacement therapy and thrombosis.
  • Anticoagulant medications, including reversal of anticoagulation (indications and tools), Warfarin dosing induction and maintenance, and the role of thrombolytics for pulmonary embolism and deep vein thrombosis,
  • Post-phlebitic syndrome, diagnosis and management.
  • Diagnosis and management of heparin allergies and warfarin allergies.

Evaluation Criteria

The fellows will be evaluated on the basis of their accomplishment of the objectives outlined above using a daily appraisal of the fellow’s skills as well as a formal appraisal of the academic activities in which he will be involved (i.e. rounds).

In order to standardize evaluations for trainees within the Division of Hematology, Thrombosis Fellows will be evaluated using the electronic One45 system through the University of Ottawa. Evaluations for outpatient clinics will occur every 6 months and for in-patient services will be completed monthly. Individual meetings with Thrombosis Fellows will take place every 6 months to review and discuss the evaluations.

At the end of the fellowship clinical fellows should be able to:

  • Describe the physiology and pathophysiology of the thrombotic diseases as well as the conditions leading to their development, including in-depth knowledge of thrombophilic states.
  • Describe the clinical characteristics and the key aspects for diagnosis of thrombotic diseases. The fellow is expected to adequately order and interpret all diagnostic studies for thrombotic diseases.
  • Provide adequate treatment and follow up to patients with thrombotic diseases.
  • Describe and provide advice on the prognosis and complications of thrombotic diseases.
  • Describe the epidemiological aspects of thrombotic diseases.
  • Interact with and provide advice to other medical specialists regarding thrombotic diseases in different fields of medicine.

 

Malignant Hematology Fellowship Program

Leukemia Fellowship Program

The Leukemia Fellowship Program is a 1-year clinical fellowship designed to train hematologists with special knowledge and expertise in leukemia and related disorders (acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, bone marrow failure syndromes, myeloproliferative neoplasms). The program is run by the academic tertiary care subspecialty Leukemia Service at The Ottawa Hospital/University of Ottawa, whose members are engaged in a variety of clinical and research activities focused on the diagnosis and treatment of leukemia and related disorders. Our program sees approximately 100 patients with a new diagnosis of acute leukemia and 50 patients with a new diagnosis of MDS annually. Leukemia fellows will have a wide variety of clinical exposure in both the inpatient and out-patient settings, participation in academic activities and teaching, and have the opportunity to participate in clinical research.

This fellowship is funded by the Ontario Ministry of Health through Cancer Care Ontario and has an associated 2-year return of service.  The applicant must submit a letter of intent, curriculum vitae, and 3 reference letters. Applicants must have completed 3 years of residency in internal medicine and 2 years of residency in hematology to be considered. Application timing is flexible; please contact us for further information.

Stem Cell Transplant Program

The Stem Cell Transplant (SCT) Program is a 2-year clinical/research fellowship. The program is run by the Malignant Hematology and Stem Cell Transplant Services at The Ottawa Hospital/University of Ottawa, whose members are engaged in a variety of clinical and research activities. SCT fellows will have exposure to a wide variety of hematologic malignancies with a focus on allogeneic and autologous stem cell transplantation. We have a large transplant program, performing 83 autologous transplants and 97 allogeneic transplants in 2017, and we are on track to perform 220 transplants in 2018. In addition to a research focus and expertise in cellular therapy for hematologic malignancies, we also perform transplantation and conduct research in patients with autoimmune disorders. Fellows will have rotations in inpatient and outpatient stem cell transplantation and malignant hematology, transplant laboratories (HLA lab, genetics, and Canadian Blood Services), Apheresis, and SCT subspecialty services (i.e. SCT infectious diseases).  Scholarly activity is a required part of the fellowship, and will be tailored to the trainee pending interest and career plan. Those with a stronger research interest may pursue a relevant Masters Degree.

This fellowship is funded by the Ontario Ministry of Health through Cancer Care Ontario and has an associated 2-year return of service.  The applicant must submit a letter of intent, curriculum vitae, and 3 reference letters. Applicants must have a minimum of 3 years of internal medicine residency and 2 years of hematology residency training to be considered. Application timing is flexible; please contact us for further information.

Malignant Hematology and Stem Cell Transplant Program

The Malignant Hematology and Stem Cell Transplant (SCT) Program is a 1-2 year program in either malignant hematology, stem cell transplantation, or both. The fellowship training is tailored to the interests and needs of the trainee, and typically includes both clinical and research components designed to meet the skills and knowledge requirements as a subspecialist in malignant hematology/SCT. Applicants with a stronger research interest can consider completing a Masters or expended laboratory experience depending on the trainee.

This fellowship does not have associated funding. However, interested applicants should contact us to explore options to access funding through alternative sources. The applicant must submit a letter of intent, curriculum vitae, and 3 reference letters. Applicants must have a minimum of 3 years of internal medicine residency and 2 years of hematology residency training to be considered.

Application timing is flexible; please contact us for further information.

 

CONTACT US

Hematology Residency Thrombosis Fellowship  Malignant Hematology Fellowship 
Program Director  Dr. Andrea Kew  Dr. Marc Carrier  Dr. Arleigh McCurdy
Email  akew@toh.ca  mcarrier@toh.ca  amccurdy@toh.ca
Telephone  (613) 737-8899 x 71281  (613) 737-8899 x 73034  (613) 737-8899 x 71281
Assistant  Kim Hutson-Ladouceur  Cathy McSheffery Kim Hutson-Ladouceur

 

Education Coordinator: Alycia-Anne Martin